Black Creek Investment Management Inc. Merck & Co., Inc. Transaction History

Black Creek Investment Management Inc.

$2.82 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $3.5 Million - $3.76 Million	-28,253 Reduced 21.68%	102,047 $12.6 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $226,480 - $263,900	-2,000 Reduced 1.51%	130,300 $17.2 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $8.01 Million - $8.72 Million	-80,000 Reduced 37.68%	132,300 $14.4 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $3.05 Million - $3.38 Million	29,600 Added 16.2%	212,300 $21.9 Million
Q2 2023 Aug 10, 2023	BUY	$108.61 - $118.38 $15.1 Million - $16.5 Million	139,200 Added 320.0%	182,700 $21.1 Million
Q1 2023 May 09, 2023	BUY	$102.94 - $114.86 $463,230 - $516,870	4,500 Added 11.54%	43,500 $4.63 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $4.9 Million - $6.28 Million	-56,000 Reduced 58.95%	39,000 $4.33 Million
Q3 2022 Nov 09, 2022	SELL	$84.53 - $94.96 $5.66 Million - $6.36 Million	-67,000 Reduced 41.36%	95,000 $8.18 Million
Q2 2022 Aug 11, 2022	SELL	$83.49 - $94.64 $22 Million - $25 Million	-264,000 Reduced 61.97%	162,000 $14.8 Million
Q1 2022 May 06, 2022	BUY	$73.51 - $82.4 $735,100 - $824,000	10,000 Added 2.4%	426,000 $35 Million
Q4 2021 Feb 15, 2022	SELL	$72.28 - $90.54 $216,840 - $271,620	-3,000 Reduced 0.72%	416,000 $31.9 Million
Q3 2021 Nov 05, 2021	BUY	$71.68 - $78.83 $4.44 Million - $4.89 Million	62,000 Added 17.37%	419,000 $31.5 Million
Q2 2021 Aug 12, 2021	SELL	$70.31 - $77.77 $6.33 Million - $7 Million	-90,000 Reduced 20.13%	357,000 $27.8 Million
Q1 2021 May 06, 2021	BUY	$68.86 - $81.11 $8.06 Million - $9.49 Million	117,000 Added 35.45%	447,000 $34.5 Million
Q4 2020 Feb 08, 2021	BUY	$71.77 - $79.65 $1.92 Million - $2.13 Million	26,700 Added 8.8%	330,000 $27 Million
Q3 2020 Nov 09, 2020	SELL	$73.18 - $82.95 $2.73 Million - $3.09 Million	-37,300 Reduced 10.95%	303,300 $25.2 Million
Q2 2020 Aug 11, 2020	SELL	$70.42 - $80.13 $1.76 Million - $2 Million	-25,000 Reduced 6.84%	340,600 $26.3 Million
Q1 2020 May 08, 2020	SELL	$63.36 - $87.82 $6.71 Million - $9.3 Million	-105,900 Reduced 22.46%	365,600 $28.1 Million
Q4 2019 Feb 11, 2020	BUY	$77.58 - $87.54 $31,032 - $35,016	400 Added 0.08%	471,500 $42.9 Million
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $1.55 Million - $1.69 Million	-20,400 Reduced 4.15%	471,100 $39.7 Million
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $4.43 Million - $5.17 Million	63,400 Added 14.81%	491,500 $41.2 Million
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $1.23 Million - $1.4 Million	-17,700 Reduced 3.97%	428,100 $35.6 Million
Q4 2018 Feb 12, 2019	SELL	$65.24 - $75.71 $11.4 Million - $13.2 Million	-174,700 Reduced 28.15%	445,800 $34.1 Million
Q3 2018 Nov 09, 2018	SELL	$57.69 - $67.84 $11.6 Million - $13.7 Million	-201,500 Reduced 24.51%	620,500 $44 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $4.5 Million - $5.29 Million	88,500 Added 12.07%	822,000 $49.9 Million
Q1 2018 May 11, 2018	BUY	$50.96 - $59.23 $14 Million - $16.3 Million	275,500 Added 60.15%	733,500 $40 Million
Q4 2017 Feb 09, 2018	BUY	$51.62 - $61.64 $23.6 Million - $28.2 Million	458,000	458,000 $25.8 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$24.6 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.4 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.7 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.46 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.82 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Creek Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Creek Investment Management Inc. with notifications on news.

Account